BACKGROUND OF THE INVENTION
Field of the Invention
[0001] The present invention relates to enzymatic water-soluble films comprising protease
inhibitors, and their use in detergents.
Background
[0002] The use of water-soluble film packages to deliver unit dosage amounts of detergents
products for e.g. laundry and automatic dish wash is well known (see e.g.,
WO 2009/098660 or
WO 2010/141301). Both granular and liquid detergents have been on the market in this form for several
years. It is also well known for decades to use enzymes in laundry detergents. More
and more different types of enzymes are used in detergents, and the dosages of the
enzymes is also increasing, amongst others due to the benefits coming from the enzymes
and the environmental benefits of using biological actives instead of e.g. oil based
chemicals like most surfactants.
[0003] A potential problem when using enzymes in detergents is the storage stability of
the enzymes. Enzymes are large biological molecules that can undergo various forms
of degradation. To overcome this problem numerous solutions have been suggested and
patented, involving both designing more robust enzymes, and making detergent formulations
less harsh to the enzymes. For unit dose systems like detergent pouches or tablets
it is often useful to separate the enzymes from more harsh chemicals (e.g., bleach)
in different compartments or layers. However, this is complicating the manufacturing
processes and increases the cost. It has previously been suggested to incorporate
the enzymes into the water-soluble film surrounding a detergent pouch (e.g.,
US 4,115,292).
[0004] Even when enzymes are protected from chemicals in the detergent composition, other
enzymes in the film - in particular proteases - may influence stability of the enzymes
during storage. Storage stability is not the only issue. During production of the
film, the enzymes are active in the liquid used for preparing (casting) the film,
and proteolytic activity exhibited by proteases will negatively influence the residual
activity of all enzymes in the final film product. This is of particular importance
when film offcuts from the cutting step is processed for reuse in the casting of new
film.
[0005] The present invention provides a solution for both increasing the storage stability
of enzymes in a water-soluble film, and for increasing the residual activity of enzymes
in a water-soluble film.
SUMMARY OF THE INVENTION
[0006] In a first aspect, the present invention provides a water-soluble film comprising
a protease and a protease inhibitor.
[0007] Various other aspects and embodiments are apparent from the detailed description,
examples and claims.
DETAILED DESCRIPTION OF THE INVENTION
[0008] The inventors of the present invention have surprisingly found that the storage stability
of enzymes incorporated in a water-soluble film, which contains at least one protease,
can be improved by including a protease inhibitor in the film. Even though the water
activity in the film is very low, and therefore the enzymatic activity is also low,
the protease activity influences the storage stability of both proteases and other
enzymes in the film. This is a surprising discovery, because proteases (and other
hydrolytic enzymes) need water to exhibit proteolytic (hydrolytic) activity.
[0009] In addition, the inventors have found that by including a protease inhibitor in a
water-soluble film, which contains at least one protease, the loss of enzymatic activity
during production of the film can be reduced. During production, the film is prepared
from a liquid composition, wherein the protease exhibits proteolytic activity towards
other proteases (autoproteolysis) and towards other enzymes and proteins. Therefore,
the invention provides a higher residual activity of the enzymes in the water-soluble
film after production.
Enzymes
[0010] The enzyme(s) comprised in the enzyme and protease inhibitor containing water-soluble
film of the invention include at least one protease, and optionally one or more (other)
enzymes such as a protease, lipase, cutinase, amylase, carbohydrase, cellulase, pectinase,
mannanase, arabinase, galactanase, xylanase, oxidase, e.g., laccase, peroxidase and/or
haloperoxidase.
[0011] Proteases: The proteases for use in the present invention are serine proteases, such as subtilisins,
metalloproteases and/or trypsin-like proteases. Preferably, the proteases are subtilisins.
[0012] A serine protease is an enzyme which catalyzes the hydrolysis of peptide bonds, and
in which there is an essential serine residue at the active site (
White, Handler and Smith, 1973 "Principles of Biochemistry," Fifth Edition, McGraw-Hill
Book Company, NY, pp. 271-272). Subtilisins include, preferably consist of, the I-S1 and I-S2 sub-groups as defined
by
Siezen et al., Protein Engng. 4 (1991) 719-737; and
Siezen et al., Protein Science 6 (1997) 501-523. Because of the highly conserved structure of the active site of serine proteases,
the subtilisin according to the invention may be functionally equivalent to the proposed
sub-group designated subtilase by Siezen
et al. (supra).
[0013] The subtilisin may be of animal, vegetable or microbial origin, including chemically
or genetically modified mutants (protein engineered variants), preferably an alkaline
microbial subtilisin. Examples of subtilisins are those derived from
Bacillus, e.g., subtilisin Novo, subtilisin Carlsberg, subtilisin BPN', subtilisin 309, subtilisin
147 and subtilisin 168 (described in
WO 89/06279) and Protease PD138 (
WO 93/18140). Examples are described in
WO 98/020115,
WO 01/44452,
WO 01/58275,
WO 01/58276,
WO 03/006602 and
WO 04/099401. Examples of trypsin-like proteases are trypsin (e.g., of porcine or bovine origin)
and the
Fusarium protease described in
WO 89/06270 and
WO 94/25583. Other examples are the variants described in
WO 92/19729,
WO 88/08028,
WO 98/20115,
WO 98/20116,
WO 98/34946,
WO 2000/037599,
WO 2011/036263, especially the variants with substitutions in one or more of the following positions:
27, 36, 57, 76, 87, 97, 101, 104, 120, 123, 167, 170, 194, 206, 218, 222, 224, 235,
and 274.
[0014] Examples of commercially available subtilisins include Kannase™, Everlase™, Relase™,
Esperase™, Alcalase™, Durazym™, Savinase™, Ovozyme™, Liquanase™, Coronase™, Polarzyme™,
Pyrase™, Pancreatic Trypsin NOVO (PTN), Bio-Feed™ Pro and Clear-Lens™ Pro; Blaze (all
available from Novozymes A/S, Bagsvaerd, Denmark). Other commercially available proteases
include Ronozyme™ Pro, Maxatase™, Maxacal™, Maxapem™, Opticlean™, Properase™, Purafast™,
Purafect™, Purafect Ox™, Purafact Prime™, Excellase™, FN2™, FN3™ and FN4™ (available
from Genencor International Inc., Gist-Brocades, BASF, or DSM). Other examples are
Primase™ and Duralase™. Blap R, Blap S and Blap X available from Henkel are also examples.
[0015] Cellulases: Suitable cellulases include those of bacterial or fungal origin. Chemically modified
or protein engineered mutants are included. Suitable cellulases include cellulases
from the genera
Bacillus, Pseudomonas, Humicola, Fusarium, Thielavia, Acremonium, e.g., the fungal cellulases produced from
Humicola insolens, Myceliophthora thermophila and
Fusarium oxysporum disclosed in
US 4,435,307,
US 5,648,263,
US 5,691,178,
US 5,776,757 and
WO 89/09259.
[0016] Especially suitable cellulases are the alkaline or neutral cellulases having color
care benefits. Examples of such cellulases are cellulases described in
EP 0 495 257,
EP 0 531 372,
WO 96/11262,
WO 96/29397,
WO 98/08940. Other examples are cellulase variants such as those described in
WO 94/07998,
EP 0 531 315,
US 5,457,046,
US 5,686,593,
US 5,763,254,
WO 95/24471,
WO 98/12307 and
PCT/DK98/00299.
[0017] Commercially available cellulases include Celluzyme™, and Carezyme™ (Novozymes A/S),
Clazinase™, and Puradax HA™ (Genencor International Inc.), and KAC-500(B)™ (Kao Corporation).
[0018] Lipases and Cutinases: Suitable lipases and cutinases include those of bacterial or fungal origin. Chemically
modified or protein engineered mutants are included. Examples include lipase from
Thermomyces, e.g., from
T. lanuginosus (previously named
Humicola lanuginosa) as described in
EP 258 068 and
EP 305 216, cutinase from
Humicola, e.g. H. insolens as described in
WO 96/13580, a
Pseudomonas lipase, e.g., from
P. alcaligenes or P.
pseudoalcaligenes (
EP 218 272),
P. cepacia (
EP 331 376),
P. stutzeri (
GB 1,372,034), P.
fluorescens, Pseudomonas sp. strain SD 705 (
WO 95/06720 and
WO 96/27002), P.
wisconsinensis (
WO 96/12012), a
Bacillus lipase, e.g., from B.
subtilis (
Dartois et al., 1993, Biochemica et Biophysica Acta, 1131: 253-360), B.
stearothermophilus (
JP 64/744992) or B.
pumilus (
WO 91/16422).
[0019] Other examples are lipase variants such as those described in
WO 92/05249,
WO 94/01541,
EP 407 225,
EP 260 105,
WO 95/35381,
WO 96/00292,
WO 95/30744,
WO 94/25578,
WO 95/14783,
WO 95/22615,
WO 97/04079,
WO 97/07202,
WO 00/060063,
WO2007/087508 and
WO 2009/109500.
[0020] Preferred commercially available lipase enzymes include Lipolase
™, Lipolase Ultra
™, and Lipex
™; Lecitase
™, Lipolex
™; Lipoclean
™, Lipoprime
™ (Novozymes A/S). Other commercially available lipases include Lumafast (Genencor
Int Inc); Lipomax (Gist-Brocades/Genencor Int Inc) and Bacillus sp lipase from Solvay.
[0021] Amylases: Suitable amylases (α and/or β) include those of bacterial or fungal origin. Chemically
modified or protein engineered mutants are included. Amylases include, for example,
α-amylases obtained from
Bacillus,
e.g., a special strain of
Bacillus licheniformis, described in more detail in
GB 1,296,839.
[0022] Examples of useful amylases are the variants described in
WO 94/02597,
WO 94/18314,
WO 96/23873, and
WO 97/43424, especially the variants with substitutions in one or more of the following positions:
15, 23, 105, 106, 124, 128, 133, 154, 156, 181, 188, 190, 197, 202, 208, 209, 243,
264, 304, 305, 391, 408, and 444.
[0023] Commercially available amylases are Duramyl
™, Termamyl
™, Fungamyl
™ and BAN
™ (Novozymes A/S), Rapidase
™ and Purastar
™ (from Genencor International Inc.).
[0024] Oxidases: Suitable oxidases (or oxidoreductases) include various sugar oxidases, laccases,
peroxidases and haloperoxidases.
Polyol
[0025] Polyols are often used as enzyme formulation agents, and may therefore eventually
become a component of the water-soluble film, when a liquid enzyme formulation is
used for preparing the water-soluble film. As described below under "Water-soluble
film", polyols are also often used as plasticizers in water-soluble film.
[0026] A polyol (or polyhydric alcohol), when used as a component in the water-soluble film
according to the invention, is an alcohol with two or more hydroxyl groups. The polyol
typically includes less than 10 carbons, such as 9, 8, 7, 6, 5, 4, or 3 carbons. The
molecular weight is typically less than 500 g/mol, such as 400 g/mol or 300 g/mol.
[0027] Examples of suitable polyols include, but are not limited to, glycerol, propylene
glycol, ethylene glycol, sorbitol, mannitol, erythritol, dulcitol, inositol, xylitol
and adonitol.
[0028] Generally, the water-soluble film of the invention includes less than 10% (w/w) polyol
(polyhydric alcohol) per percent of active enzyme, i.e. the weight ratio of polyol
to active enzyme is less than 10. Preferably, the weight ratio of polyol to active
enzyme is less than 9, more preferably less than 8, more preferably less than 7, more
preferably less than 6, more preferably less than 5, more preferably less than 4,
most preferably less than 3, and in particular less than 2.
[0029] In an embodiment, the amount of polyol(s) in the water-soluble film is 10% to 50%
(w/w), preferably 20% to 50% (w/w), more preferably 25% to 50% (w/w), even more preferably
less than 25% to 45% (w/w), and most preferably less than 30% to 45% (w/w).
Protease Inhibitor
[0030] The protease inhibitor according to the invention is a reversible inhibitor of serine
protease activity. Preferably, the protease inhibitor is a (reversible) subtilisin
protease inhibitor. In particular, the protease inhibitor may be a peptide aldehyde
or a boronic acid derivative.
[0031] The inhibitor may have an inhibition constant to a serine protease Ki (M, mol/L)
of from 1 E-12 to 1 E-03; more preferred from 1 E-11 to 1 E-04; even more preferred
from 1 E-10 to 1 E-05; even more preferred from 1 E-1 0 to 1 E-06; and most preferred
from 1 E-09 to 1 E-07.
[0032] The protease inhibitor according to the invention may be boronic acid or a derivative
thereof; preferably, phenylboronic acid or a derivative thereof. We have found that
inclusion of boronic acids in the amounts needed in polyvinylalcohol based water soluble
films does not create problems with solubility of the water-soluble film.
[0033] In an embodiment of the invention, the phenyl boronic acid derivative is of the following
formula:

wherein R is selected from the group consisting of hydrogen, hydroxy, C
1-C
6 alkyl, substituted C
1-C
6 alkyl, C
1-C
6 alkenyl and substituted C
1-C
6 alkenyl. Preferably, R is hydrogen, CH
3, CH
3CH
2 or CH
3CH
2CH
2.
[0034] In a preferred embodiment, the protease inhibitor (phenyl boronic acid derivative)
is 4-formyl-phenyl-boronic acid (4-FPBA).
[0035] In another particular embodiment, the protease inhibitor is selected from the group
consisting of:
thiophene-2 boronic acid, thiophene-3 boronic acid, acetamidophenyl boronic acid,
benzofuran-2 boronic acid, naphtalene-1 boronic acid, naphtalene-2 boronic acid, 2-FPBA,
3-FBPA, 4-FPBA, 1-thianthrene boronic acid, 4-dibenzofuran boronic acid, 5-methylthiophene-2
boronic, acid, thionaphtrene boronic acid, furan-2 boronic acid, furan-3 boronic acid,
4,4 biphenyl-diborinic acid, 6-hydroxy-2-naphtalene, 4-(methylthio) phenyl boronic
acid, 4 (trimethylsilyl)phenyl boronic acid, 3-bromothiophene boronic acid, 4-methylthiophene
boronic acid, 2-naphtyl boronic acid, 5-bromothiphene boronic acid, 5-chlorothiophene
boronic acid, dimethylthiophene boronic acid, 2-bromophenyl boronic acid, 3-chlorophenyl
boronic acid, 3-methoxy-2-thiophene, p-methyl-phenylethyl boronic acid, 2-thianthrene
boronic acid, dibenzothiophene boronic acid, 4-carboxyphenyl boronic acid, 9-anthryl
boronic acid, 3,5 dichlorophenyl boronic, acid, diphenyl boronic acidanhydride, o-chlorophenyl
boronic acid, p-chlorophenyl boronic acid, m-bromophenyl boronic acid, p-bromophenyl
boronic acid, p-flourophenyl boronic acid, p-tolyl boronic acid, o-tolyl boronic acid,
octyl boronic acid, 1,3,5 trimethylphenyl boronic acid, 3-chloro-4-flourophenyl boronic
acid, 3-aminophenyl boronic acid, 3,5-bis-(triflouromethyl) phenyl boronic acid, 2,4
dichlorophenyl boronic acid, 4-methoxyphenyl boronic acid.
[0036] Further boronic acid derivatives suitable as protease inhibitors according to the
invention are described in
US 4,963,655,
US 5,159,060,
WO 95/12655,
WO 95/29223,
WO 92/19707,
WO 94/04653,
WO 94/04654,
US 5442100,
US 5488157 and
US 5472628.
[0037] The protease inhibitor according to the invention may also be a peptide aldehyde
having the formula X-B
1-B
0-H, wherein the groups have the following meaning:
- a) H is hydrogen;
- b) B0 is a single amino acid residue with L- or D-configuration and with the formula: NH-CHR-CO;
- c) B1 is a single amino acid residue; and
- d) X consists of one or more amino acid residues (preferably one or two), optionally
comprising
an N-terminal protection group.
[0038] NH-CHR-CO (B
0) is an L or D-amino acid residue, where R may be an aliphatic or aromatic side chain,
e.g., aralkyl, such as benzyl, where R may be optionally substituted. More particularly,
the B
0 residue may be bulky, neutral, polar, hydrophobic and/or aromatic. Examples are the
D- or L-form of Tyr (p-tyrosine), m-tyrosine, 3,4-dihydroxyphenylalanine, Phe, Val,
Met, norvaline (Nva), Leu, Ile or norleucine (Nle).
[0039] In the above formula, X-B
1-B
0-H, the B
1 residue may particularly be small, aliphatic, hydrophobic and/or neutral. Examples
are alanine (Ala), cysteine (Cys), glycine (Gly), proline (Pro), serine (Ser), threonine
(Thr), valine (Val), norvaline (Nva) and norleucine (Nle), particularly alanine, glycine,
or valine.
[0040] X may in particular be one or two amino acid residues with an optional N-terminal
protection group (i.e. the compound is a tri- or tetrapeptide aldehyde with or without
a protection group). Thus, X may be B
2, B
3-B
2, Z-B
2, or Z-B
3-B
2 where B
3 and B
2 each represents one amino acid residue, and Z is an N-terminal protection group.
The B
2 residue may in particular be small, aliphatic and/or neutral, e.g., Ala, Gly, Thr,
Arg, Leu, Phe or Val. The B
3 residue may in particular be bulky, hydrophobic, neutral and/or aromatic, e.g., Phe,
Tyr, Trp, Phenylglycine, Leu, Val, Nva, Nle or Ile.
[0041] The N-terminal protection group Z (if present) may be selected from formyl, acetyl,
benzoyl, trifluoroacetyl, fluoromethoxy carbonyl, methoxysuccinyl, aromatic and aliphatic
urethane protecting groups, benzyloxycarbonyl (Cbz), t-butyloxycarbonyl, adamantyloxycarbonyl,
p-methoxybenzyl carbonyl (MOZ), benzyl (Bn), p-methoxybenzyl (PMB) or p-methoxyphenyl
(PMP), methoxycarbonyl (Moc); methoxyacetyl (Mac); methyl carbamate or a methylamino
carbonyl/methyl urea group. In the case of a tripeptide aldehyde with a protection
group (i.e. X = Z-B
2), Z is preferably a small aliphatic group, e.g., formyl, acetyl, fluoromethoxy carbonyl,
t-butyloxycarbonyl, methoxycarbonyl (Moc); methoxyacetyl (Mac); methyl carbamate or
a Methylamino carbonyl/methyl urea group. In the case of a tripeptide aldehyde with
a protection group (i.e. X = Z-B
3-B
2), Z is preferably a bulky aromatic group such as benzoyl, benzyloxycarbonyl, p-methoxybenzyl
carbonyl (MOZ), benzyl (Bn), p-methoxybenzyl (PMB) or p-methoxyphenyl (PMP).
[0042] Suitable peptide aldehydes are described in
WO 94/04651,
WO 95/25791,
WO 98/13458,
WO 98/13459,
WO 98/13460,
WO 98/13461,
WO 98/13461,
WO 98/13462,
WO 2007/141736,
2007/145963,
WO 2009/118375,
WO 2010/055052 and
WO 2011/036153. More particularly, the peptide aldehyde may be Cbz-RAY-H, Ac-GAY-H, Cbz-GAY-H, Cbz-GAL-H,
Cbz-VAL-H, Cbz-GAF-H, Cbz-GAV-H, Cbz-GGY-H, Cbz-GGF-H, Cbz-RVY-H, Cbz-LVY-H, Ac-LGAY-H,
Ac-FGAY-H, Ac-YGAY-H, Ac-FGAL-H, Ac-FGAF-H, Ac-FGVY-H, Ac-FGAM-H, Ac-WLVY-H, MeO-CO-VAL-H,
MeNCO-VAL-H, MeO-CO-FGAL-H, MeO-CO-FGAF-H, MeSO
2-FGAL-H, MeSO
2-VAL-H, PhCH
2O(OH)(O)P-VAL-H, EtSO
2-FGAL-H, PhCH
2SO
2-VAL-H, PhCH
2O(OH)(O)P-LAL-H, PhCH
2O(OH)(O)P-FAL-H, or MeO(OH)(O)P-LGAL-H. Here, Cbz is benzyloxycarbonyl, Me is methyl,
Et is ethyl, Ac is acetyl, H is hydrogen, and the other letters represent amino acid
residues denoted by standard single letter notification (e.g., F = Phe, Y = Tyr, L
= Leu).
[0043] Alternatively, the peptide aldehyde may have the formula as described in
WO 2011/036153:
P-O-(A
i-X')
n-A
n+1-Q
wherein Q is hydrogen, CH
3, CX
3, CHX
2, or CH
2X, wherein X is a halogen atom;
wherein one X' is the "double N-capping group" CO, CO-CO, CS, CS-CS or CS-CO, most
preferred urido (CO), and the other X' es are nothing,
wherein n = 1-10, preferably 2-5, most preferably 2,
wherein each of A
i and A
n+1 is an amino acid residue having the structure:
-NH-CR-CO- for a residue to the right of X= -CO-, or
-CO-CR-NH- for a residue to the left of X= -CO-
wherein R is H- or an optionally substituted alkyl or alkylaryl group which may optionally
include a hetero atom and may optionally be linked to the N atom, and
wherein P is hydrogen or any C-terminal protection group.
[0044] Examples of such peptide aldehydes include α-MAPI, β-MAPI, F-urea-RVY-H, F-urea-GGY-H,
F-urea-GAF-H, F-urea-GAY-H, F-urea-GAL-H, F-urea-GA-Nva-H, F-urea-GA-Nle-H, Y-urea-RVY-H,
Y-urea-GAY-H, F-CS-RVF-H, F-CS-RVY-H, F-CS-GAY-H, Antipain, GE20372A, GE20372B, Chymostatin
A, Chymostatin B, and Chymostatin C. Further examples of peptide aldehydes are disclosed
in
WO 2010/055052 and
WO 2009/118375,
WO 94/04651,
WO 98/13459,
WO 98/13461,
WO 98/13462,
WO 2007/145963, (P&G) hereby incorporated by reference.
[0045] Alternatively to a peptide aldehyde, the protease inhibitor may be a hydrosulfite
adduct having the formula X-B
1-NH-CHR-CHOH-SO
3M, wherein X, B
1 and R are defined as above, and M is H or an alkali metal, preferably Na or K.
[0048] Formate salts (e.g. sodium formate) and formic acid have also shown good effects
as inhibitor of protease activity.
[0049] In a preferred embodiment of this invention the protease is a metalloprotease and
the inhibitor is a metalloprotease inhibitor, e.g., a protein hydrolysate based inhibitor
(e.g., as described in
WO 2008/134343).
Water-soluble film
[0050] Water-soluble films, optional ingredients for use therein, and methods of making
the same are well known in the art. In one class of embodiments, the water-soluble
film includes PVOH. PVOH is a synthetic resin generally prepared by the alcoholysis,
usually termed hydrolysis or saponification, of polyvinyl acetate. Fully hydrolyzed
PVOH, wherein virtually all the acetate groups have been converted to alcohol groups,
is a strongly hydrogen-bonded, highly crystalline polymer which dissolves only in
hot water - greater than about 140°F (60°C). If a sufficient number of acetate groups
are allowed to remain after the hydrolysis of polyvinyl acetate, the PVOH polymer
then being known as partially hydrolyzed, it is more weakly hydrogen-bonded and less
crystalline and is soluble in cold water - less than about 50°F (10°C). An intermediate
cold/hot water-soluble film can include, for example, intermediate partially-hydrolyzed
PVOH (e.g., with degrees of hydrolysis of about 94% to about 98%), and is readily
soluble only in warm water - e.g., rapid dissolution at temperatures of about 40°C
and greater. Both fully and partially hydrolyzed PVOH types are commonly referred
to as PVOH homopolymers although the partially hydrolyzed type is technically a vinyl
alcohol-vinyl acetate copolymer.
[0051] The degree of hydrolysis of the PVOH included in the water-soluble films of the present
disclosure can be about 75% to about 99%. As the degree of hydrolysis is reduced,
a film made from the resin will have reduced mechanical strength but faster solubility
at temperatures below about 20°C. As the degree of hydrolysis increases, a film made
from the resin will tend to be mechanically stronger and the thermoformability will
tend to decrease. The degree of hydrolysis of the PVOH can be chosen such that the
water-solubility of the resin is temperature dependent, and thus the solubility of
a film made from the resin, compatibilizing agent, and additional ingredients is also
influenced. In one class of embodiments the film is cold water-soluble. A cold water-soluble
film, soluble in water at a temperature of less than 10°C, can include PVOH with a
degree of hydrolysis in a range of about 75% to about 90%, or in a range of about
80% to about 90%, or in a range of about 85% to about 90%. In another class of embodiments
the film is hot water-soluble. A hot water-soluble film, soluble in water at a temperature
of at least about 60°C, can include PVOH with a degree of hydrolysis of at least about
98%.
[0052] Other film-forming resins for use in addition to or in an alternative to PVOH can
include, but are not limited to, modified polyvinyl alcohols, polyacrylates, water-soluble
acrylate copolymers, polyacrylates, polyacryamides, polyvinyl pyrrolidone, pullulan,
water-soluble natural polymers including, but not limited to, guar gum, xanthan gum,
carrageenan, and starch, water-soluble polymer derivatives including, but not limited
to, ethoxylated starch and hydroxypropylated starch, poly(sodium acrylamido-2-methylpropane
sulfonate), polymonomethylmaleate, copolymers thereof, and combinations of any of
the foregoing. In one class of embodiments, the film-forming resin is a terpolymer
consisting of vinyl alcohol, vinyl acetate, and sodium acrylamido-2-methylpropanesulfonate.
Unexpectedly, water-soluble films based on a vinyl alcohol, vinyl acetate, and sodium
acrylamido-2-methylpropanesulfonate terpolymer have demonstrated a high percent recovery
of enzyme.
[0053] The water-soluble resin can be included in the water-soluble film in any suitable
amount, for example an amount in a range of about 35 wt% to about 90 wt%. The preferred
weight ratio of the amount of the water-soluble resin as compared to the combined
amount of all enzymes, enzyme stabilizers, and secondary additives can be any suitable
ratio, for example a ratio in a range of about 0.5 to about 5, or about 1 to 3, or
about 1 to 2.
[0054] Water-soluble resins for use in the films described herein (including, but not limited
to PVOH resins) can be characterized by any suitable viscosity for the desired film
properties, optionally a viscosity in a range of about 5.0 to about 30.0 cP, or about
10.0 cP to about 25 cP. The viscosity of a PVOH resin is determined by measuring a
freshly made solution using a Brookfield LV type viscometer with UL adapter as described
in British Standard EN ISO 15023-2:2006 Annex E Brookfield Test method. It is international
practice to state the viscosity of 4% aqueous polyvinyl alcohol solutions at 20°C.
All PVOH viscosities specified herein in cP should be understood to refer to the viscosity
of 4% aqueous polyvinyl alcohol solution at 20°C, unless specified otherwise.
[0055] It is well known in the art that the viscosity of a PVOH resin is correlated with
the weight average molecular weight (
Mw) of the same PVOH resin, and often the viscosity is used as a proxy for
Mw. Thus, the weight average molecular weight of the water-soluble resin optionally
can be in a range of about 35,000 to about 190,000, or about 80,000 to about 160,000.
The molecular weight of the resin need only be sufficient to enable it to be molded
by suitable techniques to form a thin plastic film.
[0056] The water-soluble films according to the present disclosure may include other optional
additive ingredients including, but not limited to, plasticizers, surfactants, defoamers,
film formers, antiblocking agents, internal release agents, anti-yellowing agents
and other functional ingredients, for example in amounts suitable for their intended
purpose.
[0057] Water is recognized as a very efficient plasticizer for PVOH and other polymers;
however, the volatility of water makes its utility limited since polymer films need
to have at least some resistance (robustness) to a variety of ambient conditions including
low and high relative humidity. Glycerin is much less volatile than water and has
been well established as an effective plasticizer for PVOH and other polymers. Glycerin
or other such liquid plasticizers by themselves can cause surface "sweating" and greasiness
if the level used in the film formulation is too high. This can lead to problems in
a film such as unacceptable feel to the hand of the consumer and even blocking of
the film on the roll or in stacks of sheets if the sweating is not mitigated in some
manner, such as powdering of the surface. This could be characterized as over plasticization.
However, if too little plasticizer is added to the film the film may lack sufficient
ductility and flexibility for many end uses, for example to be converted into a final
use format such as pouches.
[0058] Plasticizers for use in water-soluble films of the present disclosure include, but
are not limited to, sorbitol, glycerol, diglycerol, propylene glycol, ethylene glycol,
diethyleneglycol, triethylene glycol, tetraethyleneglycol, polyethylene glycols up
to MW 400, 2 methyl 1, 3 propane diol, lactic acid, monoacetin, triacetin, triethyl
citrate, 1,3-butanediol, trimethylolpropane (TMP), polyether triol, and combinations
thereof. Polyols, as described above, are generally useful as plasticizers. As less
plasticizer is used, the film can become more brittle, whereas as more plasticizer
is used the film can lose tensile strength. Plasticizers can be included in the water-soluble
films in an amount in a range of about 25 phr to about 50 phr, or from about 30 phr
to about 45 phr, or from about 32 phr to about 42 phr, for example.
[0059] Surfactants for use in water-soluble films are well known in the art. Optionally,
surfactants are included to aid in the dispersion of the resin solution upon casting.
Suitable surfactants for water-soluble films of the present disclosure include, but
are not limited to, dialkyl sulfosuccinates, lactylated fatty acid esters of glycerol
and propylene glycol, lactylic esters of fatty acids, sodium alkyl sulfates, polysorbate
20, polysorbate 60, polysorbate 65, polysorbate 80, alkyl polyethylene glycol ethers,
lecithin, acetylated fatty acid esters of glycerol and propylene glycol, sodium lauryl
sulfate, acetylated esters of fatty acids, myristyl dimethylamine oxide, trimethyl
tallow alkyl ammonium chloride, quaternary ammonium compounds, salts thereof and combinations
of any of the forgoing. Too little surfactant can sometimes result in a film having
holes, whereas too much surfactant can result in the film having a greasy or oily
feel from excess surfactant present on the surface of the film. Thus, surfactants
can be included in the water-soluble films in an amount of less than about 2 phr,
for example less than about 1 phr, or less than about 0.5 phr, for example.
[0060] One type of secondary component contemplated for use is a defoamer. Defoamers can
aid in coalescing of foam bubbles. Suitable defoamers for use in water-soluble films
according to the present disclosure include, but are not limited to, hydrophobic silicas,
for example silicon dioxide or fumed silica in fine particle sizes, including Foam
Blast® defoamers available from Emerald Performance Materials, including Foam Blast®
327, Foam Blast® UVD, Foam Blast® 163, Foam Blast® 269, Foam Blast® 338, Foam Blast®
290, Foam Blast® 332, Foam Blast® 349, Foam Blast® 550 and Foam Blast® 339, which
are proprietary, non-mineral oil defoamers. In embodiments, defoamers can be used
in an amount of 0.5 phr, or less, for example, 0.05 phr, 0.04 phr, 0.03 phr, 0.02
phr, or 0.01 phr. Preferably, significant amounts of silicon dioxide will be avoided,
in order to avoid stress whitening.
[0061] Processes for making water-soluble articles, including films, include casting, blow-molding,
extrusion and blown extrusion, as known in the art. One contemplated class of embodiments
is characterized by the water-soluble film described herein being formed by casting,
for example, by admixing the ingredients described herein with water to create an
aqueous mixture, for example a solution with optionally dispersed solids, applying
the mixture to a surface, and drying off water to create a film. Similarly, other
compositions can be formed by drying the mixture while it is confined in a desired
shape.
[0062] In one contemplated class of embodiments, the water-soluble film is formed by casting
a water-soluble mixture wherein the water-soluble mixture is prepared according to
the steps of:
- (a) providing a mixture of water-soluble resin, water, and any optional additives
excluding plasticizers;
- (b) boiling the mixture for 30 minutes;
- (c) degassing the mixture in an oven at a temperature of at least 40°C; optionally
in a range of 40°C to 70°C, e.g., about 65°C;
- (d) adding one or more enzymes, plasticizer, and additional water to the mixture at
a temperature of 65°C or less; and
- (e) stirring the mixture without vortex until the mixture appears substantially uniform
in color and consistency; optionally for a time period in a range of 30 minutes to
90 minutes, optionally at least 1 hour; and
casting the mixture promptly after the time period of stirring (e.g., within 4 hours,
or 2 hours, or 1 hour). If the enzyme is added to the mixture too early, e.g., with
the secondary additives or resin, the activity of the enzyme may decrease. Without
intending to be bound by any particular theory, it is believed that boiling of the
mixture with the enzyme leads to the enzyme denaturing and storing in solution for
extended periods of time also leads to a reduction in enzyme activity.
[0063] In one class of embodiments, high enzyme activity is maintained in the water-soluble
films according to the present disclosure by drying the films quickly under moderate
to mild conditions. As used herein, drying quickly refers to a drying time of less
than 24 hours, optionally less than 12 hours, optionally less than 8 hours, optionally
less than 2 hours, optionally less than 1 hour, optionally less than 45 minutes, optionally
less than 30 minutes, optionally less than 20 minutes, optionally less than 10 minutes,
for example in a range of about 6 minutes to about 10 minutes, or 8 minutes. As used
herein, moderate to mild conditions refer to drying temperatures of less than 170°F
(77°C), optionally in a range of about 150°F to about 170°F (about 66°C to about 77°C),
e.g., 165°F (74°C). As the drying temperature increases, the enzymes tend to denature
faster, whereas as the drying temperature decreases, the drying time increases, thus
exposing the enzymes to solution for an extended period of time.
[0064] The film is useful for creating a packet to contain a composition, for example laundry
or dishwashing compositions, thereby forming a pouch. The film described herein can
also be used to make a packet with two or more compartments made of the same film
or in combination with films of other polymeric materials. Additional films can, for
example, be obtained by casting, blow-molding, extrusion or blown extrusion of the
same or a different polymeric material, as known in the art. In one type of embodiment,
the polymers, copolymers or derivatives thereof suitable for use as the additional
film are selected from polyvinyl alcohols, polyvinyl pyrrolidone, polyalkylene oxides,
polyacrylic acid, cellulose, cellulose ethers, cellulose esters, cellulose amides,
polyvinyl acetates, polycarboxylic acids and salts, polyaminoacids or peptides, polyamides,
polyacrylamide, copolymers of maleic/acrylic acids, polysaccharides including starch
and gelatin, natural gums such as xanthan, and carrageenans. For example, polymers
can be selected from polyacrylates and water-soluble acrylate copolymers, methylcellulose,
carboxymethylcellulose sodium, dextrin, ethylcellulose, hydroxyethyl cellulose, hydroxypropyl
methylcellulose, maltodextrin, polymethacrylates, and combinations thereof, or selected
from polyvinyl alcohols, polyvinyl alcohol copolymers and hydroxypropyl methyl cellulose
(HPMC), and combinations thereof.
[0065] The pouches and/or packets of the present disclosure comprise at least one sealed
compartment. Thus the pouches may comprise a single compartment or multiple compartments.
The pouches may have regions with and without enzymes. In embodiments including multiple
compartments, each compartment may contain identical and/or different compositions.
In turn, the compositions may take any suitable form including, but not limited to
liquid, solid and combinations thereof (e.g., a solid suspended in a liquid). In some
embodiments, the pouches comprises a first, second and third compartment, each of
which respectively contains a different first, second and third composition. In some
embodiments, the compositions may be visually distinct as described in
EP 2258820.
[0066] The compartments of multi-compartment pouches and/or packets may be of the same or
different size(s) and/or volume(s). The compartments of the present multi-compartment
pouches can be separate or conjoined in any suitable manner. In some embodiments,
the second and/or third and/or subsequent compartments are superimposed on the first
compartment. In one embodiment, the third compartment may be superimposed on the second
compartment, which is in turn superimposed on the first compartment in a sandwich
configuration. Alternatively the second and third compartments may be superimposed
on the first compartment. However it is also equally envisaged that the first, second
and optionally third and subsequent compartments may be attached to one another in
a side by side relationship. The compartments may be packed in a string, each compartment
being individually separable by a perforation line. Hence each compartment may be
individually torn-off from the remainder of the string by the end-user,
[0067] In some embodiments, multi-compartment pouches and/or packets include three compartments
consisting of a large first compartment and two smaller compartments. The second and
third smaller compartments are superimposed on the first larger compartment. The size
and geometry of the compartments are chosen such that this arrangement is achievable.
The geometry of the compartments may be the same or different. In some embodiments
the second and optionally third compartment each has a different geometry and shape
as compared to the first compartment. In these embodiments, the second and optionally
third compartments are arranged in a design on the first compartment. The design may
be decorative, educative, or illustrative, for example to illustrate a concept or
instruction, and/or used to indicate origin of the product. In some embodiments, the
first compartment is the largest compartment having two large faces sealed around
the perimeter, and the second compartment is smaller covering less than about 75%,
or less than about 50% of the surface area of one face of the first compartment. In
embodiments in which there is a third compartment, the aforementioned structure may
be the same but the second and third compartments cover less than about 60%, or less
than about 50%, or less than about 45% of the surface area of one face of the first
compartment.
[0068] The pouches and/or packets of the present disclosure may comprise one or more different
films. For example, in single compartment embodiments, the packet may be made from
one wall that is folded onto itself and sealed at the edges, or alternatively, two
walls that are sealed together at the edges. In multiple compartment embodiments,
the packet may be made from one or more films such that any given packet compartment
may comprise walls made from a single film or multiple films having differing compositions.
In one embodiment, a multi-compartment pouch comprises at least three walls: an outer
upper wall; an outer lower wall; and a partitioning wall. The outer upper wall and
the outer lower wall are generally opposing and form the exterior of the pouch. The
partitioning wall is interior to the pouch and is secured to the generally opposing
outer walls along a seal line. The partitioning wall separates the interior of the
multi-compartment pouch into at least a first compartment and a second compartment.
In one class of embodiments, the partitioning wall may be the only enzyme containing
film thereby minimizing the exposure of the consumer to the enzymes.
[0069] Pouches and packets may be made using any suitable equipment and method. For example,
single compartment pouches may be made using vertical form filling, horizontal form
filling, or rotary drum filling techniques commonly known in the art. Such processes
may be either continuous or intermittent. The film may be dampened, and/or heated
to increase the malleability thereof. The method may also involve the use of a vacuum
to draw the film into a suitable mold. The vacuum drawing the film into the mold can
be applied for about 0.2 to about 5 seconds, or about 0.3 to about 3, or about 0.5
to about 1.5 seconds, once the film is on the horizontal portion of the surface. This
vacuum can be such that it provides an under-pressure in a range of 10 mbar to 1000
mbar, or in a range of 100 mbar to 600 mbar, for example.
[0070] The molds, in which packet s may be made, can have any shape, length, width and depth,
depending on the required dimensions of the pouches. The molds may also vary in size
and shape from one to another, if desirable. For example, the volume of the final
pouches may be about 5 ml to about 300 ml, or about 10 to 150 ml, or about 20 to about
100 ml, and that the mold sizes are adjusted accordingly.
[0071] In one embodiment, the packet includes a first and a second sealed compartment. The
second compartment is in a generally superposed relationship with the first sealed
compartment such that the second sealed compartment and the first sealed compartment
share a partitioning wall interior to the pouch.
[0072] In one embodiment, the packet including a first and a second compartment further
includes a third sealed compartment. The third sealed compartment is in a generally
superposed relationship with the first sealed compartment such that the third sealed
compartment and the first sealed compartment share a partitioning wall interior to
the pouch.
[0073] In various embodiments, the first composition and the second composition are selected
from one of the following combinations: liquid, liquid; liquid, powder; powder, powder;
and powder, liquid.
[0074] In various embodiments, the first, second and third compositions are selected from
one of the following combinations: solid, liquid, liquid and liquid, liquid, liquid.
[0075] In one embodiment, the single compartment or plurality of sealed compartments contains
a composition. The plurality of compartments may each contain the same or a different
composition. The composition is selected from a liquid, solid or combination thereof.
[0076] Heat can be applied to the film in the process commonly known as thermoforming. The
heat may be applied using any suitable means. For example, the film may be heated
directly by passing it under a heating element or through hot air, prior to feeding
it onto a surface or once on a surface. Alternatively, it may be heated indirectly,
for example by heating the surface or applying a hot item onto the film. The film
can be heated using an infrared light. The film may be heated to a temperature of
at least 50°C, for example about 50 to about 150°C, about 50 to about 120°C, about
60 to about 130°C, about 70 to about 120°C, or about 60 to about 90°C.
[0077] Alternatively, the film can be wetted by any suitable means, for example directly
by spraying a wetting agent (including water, a solution of the film composition,
a plasticizer for the film composition, or any combination of the foregoing) onto
the film, prior to feeding it onto the surface or once on the surface, or indirectly
by wetting the surface or by applying a wet item onto the film.
[0078] Once a film has been heated and/or wetted, it may be drawn into an appropriate mold,
preferably using a vacuum. The film can be thermoformed with a draw ratio of at least
about 1.5, for example, and optionally up to a draw ratio of 2, for example. The filling
of the molded film can be accomplished by utilizing any suitable means. In some embodiments,
the most preferred method will depend on the product form and required speed of filling.
In some embodiments, the molded film is filled by in-line filling techniques. The
filled, open packets are then closed forming the pouches, using a second film, by
any suitable method. This may be accomplished while in horizontal position and in
continuous, constant motion. The closing may be accomplished by continuously feeding
a second film, preferably water-soluble film, over and onto the open packets and then
preferably sealing the first and second film together, typically in the area between
the molds and thus between the packets.
[0079] Any suitable method of sealing the packet and/or the individual compartments thereof
may be utilized. Non-limiting examples of such means include heat sealing, solvent
welding, solvent or wet sealing, and combinations thereof. The water-soluble packet
and/or the individual compartments thereof can be heat sealed at a temperature of
at least 200°F (93°C), for example in a range of about 220°F (about 105°C) to about
290°F (about 145°C), or about 230°F (about 110°C) to about 280°F (about 140°C). Typically,
only the area which is to form the seal is treated with heat or solvent. The heat
or solvent can be applied by any method, typically on the closing material, and typically
only on the areas which are to form the seal. If solvent or wet sealing or welding
is used, it may be preferred that heat is also applied. Preferred wet or solvent sealing/welding
methods include selectively applying solvent onto the area between the molds, or on
the closing material, by for example, spraying or printing this onto these areas,
and then applying pressure onto these areas, to form the seal. Sealing rolls and belts
as described above (optionally also providing heat) can be used, for example.
[0080] The formed pouches may then be cut by a cutting device. Cutting can be accomplished
using any known method. It may be preferred that the cutting is also done in continuous
manner, and preferably with constant speed and preferably while in horizontal position.
The cutting device can, for example, be a sharp item, or a hot item, or a laser, whereby
in the latter cases, the hot item or laser 'burns' through the film/ sealing area.
[0081] The different compartments of a multi-compartment pouches may be made together in
a side-by-side style wherein the resulting, cojoined pouches may or may not be separated
by cutting. Alternatively, the compartments can be made separately.
[0082] In some embodiments, pouches may be made according to a process including the steps
of:
- a) forming a first compartment (as described above);
- b) forming a recess within some or all of the closed compartment formed in step (a),
to generate a second molded compartment superposed above the first compartment;
- c) filling and closing the second compartments by means of a third film;
- d) sealing the first, second and third films; and
- e) cutting the films to produce a multi-compartment pouch.
[0083] The recess formed in step (b) may be achieved by applying a vacuum to the compartment
prepared in step (a).
[0084] In some embodiments, second, and/or third compartment(s) can be made in a separate
step and then combined with the first compartment as described in
EP 2088187 or
WO 2009/152031.
[0085] In other embodiments, pouches may be made according to a process including the steps
of:
- a) forming a first compartment, optionally using heat and/or vacuum, using a first
film on a first forming machine;
- b) filling the first compartment with a first composition;
- c) on a second forming machine, deforming a second film, optionally using heat and
vacuum, to make a second and optionally third molded compartment;
- d) filling the second and optionally third compartments;
- e) sealing the second and optionally third compartment using a third film;
- f) placing the sealed second and optionally third compartments onto the first compartment;
- g) sealing the first, second and optionally third compartments; and
- h) cutting the films to produce a multi-compartment pouch.
[0086] The first and second forming machines may be selected based on their suitability
to perform the above process. In some embodiments, the first forming machine is preferably
a horizontal forming machine, and the second forming machine is preferably a rotary
drum forming machine, preferably located above the first forming machine.
[0087] It should be understood that by the use of appropriate feed stations, it may be possible
to manufacture multi-compartment pouches incorporating a number of different or distinctive
compositions and/or different or distinctive liquid, gel or paste compositions.
Detergent
[0088] The detergent, or detergent composition, which forms part of the present invention,
may be a laundry detergent or a dish wash detergent composition. Preferably, the detergent
composition is a liquid detergent composition, such as a liquid laundry or dish wash
detergent composition.
[0089] In one embodiment, the invention is directed to detergent compositions comprising
a protease and protease inhibitor containing water-soluble film, as described above,
in combination with one or more additional cleaning composition components. The choice
of additional components is within the skill of the artisan and includes conventional
ingredients, including the exemplary non-limiting components set forth below.
[0090] The choice of components may include, for textile care, the consideration of the
type of textile to be cleaned, the type and/or degree of soiling, the temperature
at which cleaning is to take place, and the formulation of the detergent product.
Although components mentioned below are categorized by general header according to
a particular functionality, this is not to be construed as a limitation, as a component
may comprise additional functionalities as will be appreciated by the skilled artisan.
Surfactants
[0091] The detergent composition may comprise one or more surfactants, which may be anionic
and/or cationic and/or non-ionic and/or semi-polar and/or zwitterionic, or a mixture
thereof. In a particular embodiment, the detergent composition includes a mixture
of one or more nonionic surfactants and one or more anionic surfactants. The surfactant(s)
is typically present at a level of from about 0.1 % to 60% by weight, such as about
1% to about 40%, or about 3% to about 20%, or about 3% to about 10%. The surfactant(s)
is chosen based on the desired cleaning application, and includes any conventional
surfactant(s) known in the art. Any surfactant known in the art for use in detergents
may be utilized.
[0092] When included therein the detergent will usually contain from about 1% to about 40%
by weight, such as from about 5% to about 30%, including from about 5% to about 15%,
or from about 20% to about 25% of an anionic surfactant. Non-limiting examples of
anionic surfactants include sulfates and sulfonates, in particular, linear alkylbenzenesulfonates
(LAS), isomers of LAS, branched alkylbenzenesulfonates (BABS), phenylalkanesulfonates,
alpha-olefinsulfonates (AOS), olefin sulfonates, alkene sulfonates, alkane-2,3-diylbis(sulfates),
hydroxyalkanesulfonates and disulfonates, alkyl sulfates (AS) such as sodium dodecyl
sulfate (SDS), fatty alcohol sulfates (FAS), primary alcohol sulfates (PAS), alcohol
ethersulfates (AES or AEOS or FES, also known as alcohol ethoxysulfates or fatty alcohol
ether sulfates), secondary alkanesulfonates (SAS), paraffin sulfonates (PS), ester
sulfonates, sulfonated fatty acid glycerol esters, alpha-sulfo fatty acid methyl esters
(alpha-SFMe or SES) including methyl ester sulfonate (MES), alkyl- or alkenylsuccinic
acid, dodecenyl/tetradecenyl succinic acid (DTSA), fatty acid derivatives of amino
acids, diesters and monoesters of sulfo-succinic acid or soap, and combinations thereof.
[0093] When included therein the detergent will usually contain from about 0.1 % to about
10% by weight of a cationic surfactant. Non-limiting examples of cationic surfactants
include alklydimethylethanolamine quat (ADMEAQ), cetyltrimethylammonium bromide (CTAB),
dimethyldistearylammonium chloride (DSDMAC), and alkylbenzyldimethylammonium, alkyl
quaternary ammonium compounds, alkoxylated quaternary ammonium (AQA) compounds, and
combinations thereof.
[0094] When included therein the detergent will usually contain from about 0.2% to about
40% by weight of a non-ionic surfactant, for example from about 0.5% to about 30%,
in particular from about 1% to about 20%, from about 3% to about 10%, such as from
about 3% to about 5%, or from about 8% to about 12%. Non-limiting examples of non-ionic
surfactants include alcohol ethoxylates (AE or AEO), alcohol propoxylates, propoxylated
fatty alcohols (PFA), alkoxylated fatty acid alkyl esters, such as ethoxylated and/or
propoxylated fatty acid alkyl esters, alkylphenol ethoxylates (APE), nonylphenol ethoxylates
(NPE), alkylpolyglycosides (APG), alkoxylated amines, fatty acid monoethanolamides
(FAM), fatty acid diethanolamides (FADA), ethoxylated fatty acid monoethanolamides
(EFAM), propoxylated fatty acid monoethanolamides (PFAM), polyhydroxy alkyl fatty
acid amides, or N-acyl N-alkyl derivatives of glucosamine (glucamides, GA, or fatty
acid glucamide, FAGA), as well as products available under the trade names SPAN and
TWEEN, and combinations thereof.
[0095] When included therein the detergent will usually contain from about 0.1% to about
20% by weight of a semipolar surfactant. Non-limiting examples of semipolar surfactants
include amine oxides (AO) such as alkyldimethylamineoxide, N-(coco alkyl)-N,N-dimethylamine
oxide and N-(tallow-alkyl)-N,N-bis(2-hydroxyethyl)amine oxide, fatty acid alkanolamides
and ethoxylated fatty acid alkanolamides, and combinations thereof.
[0096] When included therein the detergent will usually contain from about 0.1% to about
10% by weight of a zwitterionic surfactant. Non-limiting examples of zwitterionic
surfactants include betaine, alkyldimethylbetaine, sulfobetaine, and combinations
thereof.
Hydrotropes
[0097] A hydrotrope is a compound that solubilises hydrophobic compounds in aqueous solutions
(or oppositely, polar substances in a non-polar environment). Typically, hydrotropes
have both hydrophilic and a hydrophobic character (so-called amphiphilic properties
as known from surfactants); however the molecular structure of hydrotropes generally
do not favor spontaneous self-aggregation, see e.g., review by
Hodgdon and Kaler (2007), Current Opinion in Colloid & Interface Science 12: 121-128. Hydrotropes do not display a critical concentration above which self-aggregation
occurs as found for surfactants and lipids forming miceller, lamellar or other well
defined meso-phases. Instead, many hydrotropes show a continuous-type aggregation
process where the sizes of aggregates grow as concentration increases. However, many
hydrotropes alter the phase behavior, stability, and colloidal properties of systems
containing substances of polar and non-polar character, including mixtures of water,
oil, surfactants, and polymers. Hydrotropes are classically used across industries
from pharma, personal care, food, to technical applications. Use of hydrotropes in
detergent compositions allow for example more concentrated formulations of surfactants
(as in the process of compacting liquid detergents by removing water) without inducing
undesired phenomena such as phase separation or high viscosity.
[0098] The detergent may contain 0-5% by weight, such as about 0.5 to about 5%, or about
3% to about 5%, of a hydrotrope. Any hydrotrope known in the art for use in detergents
may be utilized. Non-limiting examples of hydrotropes include sodium benzene sulfonate,
sodium p-toluene sulfonate (STS), sodium xylene sulfonate (SXS), sodium cumene sulfonate
(SCS), sodium cymene sulfonate, amine oxides, alcohols and polyglycolethers, sodium
hydroxynaphthoate, sodium hydroxynaphthalene sulfonate, sodium ethylhexyl sulfate,
and combinations thereof.
Builders and Co-Builders
[0099] The detergent composition may contain about 0-65% by weight, such as about 5% to
about 50% of a detergent builder or co-builder, or a mixture thereof. In a dish wash
detergent, the level of builder is typically 40-65%, particularly 50-65%. The builder
and/or co-builder may particularly be a chelating agent that forms water-soluble complexes
with Ca and Mg. Any builder and/or co-builder known in the art for use in laundry
detergents may be utilized. Non-limiting examples of builders include zeolites, diphosphates
(pyrophosphates), triphosphates such as sodium triphosphate (STP or STPP), carbonates
such as sodium carbonate, soluble silicates such as sodium metasilicate, layered silicates
(e.g., SKS-6 from Hoechst), ethanolamines such as 2-aminoethan-1-ol (MEA), diethanolamine
(DEA, also known as iminodiethanol), triethanolamine (TEA, also known as 2,2',2"-nitrilotriethanol),
and carboxymethyl inulin (CMI), and combinations thereof.
[0100] The detergent composition may also contain 0-50% by weight, such as about 5% to about
30%, of a detergent co-builder, or a mixture thereof. The detergent composition may
include include a co-builder alone, or in combination with a builder, for example
a zeolite builder. Non-limiting examples of co-builders include homopolymers of polyacrylates
or copolymers thereof, such as poly(acrylic acid) (PAA) or copoly(acrylic acid/maleic
acid) (PAA/PMA). Further non-limiting examples include citrate, chelators such as
aminocarboxylates, aminopolycarboxylates and phosphonates, and alkyl- or alkenylsuccinic
acid. Additional specific examples include 2,2',2"-nitrilotriacetic acid (NTA), ethylenediaminetetraacetic
acid (EDTA), diethylenetriaminepentaacetic acid (DTPA), iminodisuccinic acid (IDS),
ethylenediamine-
N,N'-disuccinic acid (EDDS), methylglycinediacetic acid (MGDA), glutamic acid-N,N-diacetic
acid (GLDA), 1-hydroxyethane-1,1-diphosphonic acid (HEDP), ethylenediaminetetra(methylenephosphonic
acid) (EDTMPA), diethylenetriaminepentakis(methylenephosphonic acid) (DTMPA or DTPMPA),
N-(2-hydroxyethyl)iminodiacetic acid (EDG), aspartic acid-N-monoacetic acid (ASMA),
aspartic acid-
N,N-diacetic acid (ASDA), aspartic acid-N-monopropionic acid (ASMP), iminodisuccinic
acid (IDA),
N-(2-sulfomethyl)-aspartic acid (SMAS),
N-(2-sulfoethyl)-aspartic acid (SEAS),
N-(2-sulfomethyl)-glutamic acid (SMGL),
N-(2-sulfoethyl)-glutamic acid (SEGL),
N-methyliminodiacetic acid (MIDA), α-alanine-
N,
N-diacetic acid (α-ALDA), serine-
N,
N-diacetic acid (SEDA), isoserine-
N,
N-diacetic acid (ISDA), phenylalanine-
N,
N-diacetic acid (PHDA), anthranilic acid-
N,
N-diacetic acid (ANDA), sulfanilic acid-
N,
N-diacetic acid (SLDA), taurine-
N,
N-diacetic acid (TUDA) and sulfomethyl-N, N-diacetic acid (SMDA), N-(2-hydroxyethyl)-ethylidenediamine-
N,
N',N'-triacetate (HEDTA), diethanolglycine (DEG), diethylenetriamine penta(methylenephosphonic
acid) (DTPMP), aminotris(methylenephosphonic acid) (ATMP), and combinations and salts
thereof. Further exemplary builders and/or co-builders are described in, e.g.,
WO 2009/102854,
US 5,977,053.
Bleaching Systems
[0101] The detergent may contain 0-50% of a bleaching system. Any bleaching system known
in the art for use in laundry detergents may be utilized. Suitable bleaching system
components include bleaching catalysts, photobleaches, bleach activators, sources
of hydrogen peroxide such as sodium percarbonate and sodium perborates, preformed
peracids and mixtures thereof. Suitable preformed peracids include, but are not limited
to, peroxycarboxylic acids and salts, percarbonic acids and salts, perimidic acids
and salts, peroxymonosulfuric acids and salts, for example, Oxone (R), and mixtures
thereof. Non-limiting examples of bleaching systems include peroxide-based bleaching
systems, which may comprise, for example, an inorganic salt, including alkali metal
salts such as sodium salts of perborate (usually mono- or tetra-hydrate), percarbonate,
persulfate, perphosphate, persilicate salts, in combination with a peracid-forming
bleach activator. The term bleach activator is meant herein as a compound which reacts
with peroxygen bleach like hydrogen peroxide to form a peracid. The peracid thus formed
constitutes the activated bleach. Suitable bleach activators to be used herein include
those belonging to the class of esters amides, imides or anhydrides. Suitable examples
are tetracetylethylene diamine (TAED), sodium 4-[(3,5,5-trimethylhexanoyl)oxy]benzene
sulfonate (ISONOBS), diperoxy dodecanoic acid, 4-(dodecanoyloxy)benzenesulfonate (LOBS),
4-(decanoyloxy)benzenesulfonate, 4-(decanoyloxy)benzoate (DOBS), 4-(nonanoyloxy)-benzenesulfonate
(NOBS), and/or those disclosed in
WO 98/17767. A particular family of bleach activators of interest was disclosed in
EP 624154 and particulary preferred in that family is acetyl triethyl citrate (ATC). ATC or
a short chain triglyceride like triacetin has the advantage that it is environmental
friendly as it eventually degrades into citric acid and alcohol. Furthermore acetyl
triethyl citrate and triacetin has a good hydrolytical stability in the product upon
storage and it is an efficient bleach activator. Finally ATC provides a good building
capacity to the laundry additive. Alternatively, the bleaching system may comprise
peroxyacids of, for example, the amide, imide, or sulfone type. The bleaching system
may also comprise peracids such as 6-(phthalimido)peroxyhexanoic acid (PAP). The bleaching
system may also include a bleach catalyst. In some embodiments the bleach component
may be an organic catalyst selected from the group consisting of organic catalysts
having the following formulae:

and mixtures thereof; wherein each R
1 is independently a branched alkyl group containing from 9 to 24 carbons or linear
alkyl group containing from 11 to 24 carbons, preferably each R
1 is independently a branched alkyl group containing from 9 to 18 carbons or linear
alkyl group containing from 11 to 18 carbons, more preferably each R
1 is independently selected from the group consisting of 2-propylheptyl, 2-butyloctyl,
2-pentylnonyl, 2-hexyldecyl, n-dodecyl, n-tetradecyl, n-hexadecyl, n-octadecyl, iso-nonyl,
iso-decyl, iso-tridecyl and iso-pentadecyl. Other exemplary bleaching systems are
described, e.g., in
WO 2007/087258,
WO 2007/087244,
WO 2007/087259 and
WO 2007/087242. Suitable photobleaches may for example be sulfonated zinc phthalocyanine.
Polymers
[0102] The detergent may contain 0-10% by weight, such as 0.5-5%, 2-5%, 0.5-2% or 0.2-1
% of a polymer. Any polymer known in the art for use in detergents may be utilized.
The polymer may function as a co-builder as mentioned above, or may provide antiredeposition,
fiber protection, soil release, dye transfer inhibition, grease cleaning and/or anti-foaming
properties. Some polymers may have more than one of the above-mentioned properties
and/or more than one of the below-mentioned motifs. Exemplary polymers include (carboxymethyl)cellulose
(CMC), poly(vinyl alcohol) (PVA), poly(vinylpyrrolidone) (PVP), poly(ethyleneglycol)
or poly(ethylene oxide) (PEG), ethoxylated poly(ethyleneimine), carboxymethyl inulin
(CMI), and polycarboxylates such as PAA, PAA/PMA, poly-aspartic acid, and lauryl methacrylate/acrylic
acid copolymers , hydrophobically modified CMC (HM-CMC) and silicones, copolymers
of terephthalic acid and oligomeric glycols, copolymers of poly(ethylene terephthalate)
and poly(oxyethene terephthalate) (PET-POET), PVP, poly(vinylimidazole) (PVI), poly(vinylpyridine-N-oxide)
(PVPO or PVPNO) and polyvinylpyrrolidone-vinylimidazole (PVPVI). Further exemplary
polymers include sulfonated polycarboxylates, polyethylene oxide and polypropylene
oxide (PEO-PPO) and diquaternium ethoxy sulfate. Other exemplary polymers are disclosed
in, e.g.,
WO 2006/130575. Salts of the above-mentioned polymers are also contemplated.
Fabric hueing agents
[0103] The detergent compositions of the present invention may also include fabric hueing
agents such as dyes or pigments, which when formulated in detergent compositions can
deposit onto a fabric when said fabric is contacted with a wash liquor comprising
said detergent compositions and thus altering the tint of said fabric through absorption/reflection
of visible light. Fluorescent whitening agents emit at least some visible light. In
contrast, fabric hueing agents alter the tint of a surface as they absorb at least
a portion of the visible light spectrum. Suitable fabric hueing agents include dyes
and dye-clay conjugates, and may also include pigments. Suitable dyes include small
molecule dyes and polymeric dyes. Suitable small molecule dyes include small molecule
dyes selected from the group consisting of dyes falling into the Colour Index (C.I.)
classifications of Direct Blue, Direct Red, Direct Violet, Acid Blue, Acid Red, Acid
Violet, Basic Blue, Basic Violet and Basic Red, or mixtures thereof, for example as
described in
WO 2005/03274,
WO 2005/03275,
WO 2005/03276 and
EP 1876226 (hereby incorporated by reference). The detergent composition preferably comprises
from about 0.00003 wt% to about 0.2 wt%, from about 0.00008 wt% to about 0.05 wt%,
or even from about 0.0001 wt% to about 0.04 wt% fabric hueing agent. The composition
may comprise from 0.0001 wt% to 0.2 wt% fabric hueing agent, this may be especially
preferred when the composition is in the form of a unit dose pouch. Suitable hueing
agents are also disclosed in, e.g.,
WO 2007/087257 and
WO 2007/087243.
(Additional) Enzymes
[0104] The detergent composition may comprise one or more (other) enzymes, in addition to
the enzymes comprised in the water-soluble film. Examples of such enzymes are the
same as those, which can be included in the enzyme containing water-soluble film,
as shown above; for example protease, lipase, cutinase, amylase, carbohydrase, cellulase,
pectinase, mannanase, arabinase, galactanase, xylanase, oxidase, e.g., laccase, peroxidase
and/or haloperoxidase.
[0105] The detergent enzyme(s) may be included in a detergent composition by adding separate
additives containing one or more enzymes, or by adding a combined additive comprising
all of these enzymes. A detergent additive of the invention, i.e., a separate additive
or a combined additive, can be formulated, for example, as a granulate, liquid, slurry,
etc. Preferred detergent additive formulations are granulates, in particular non-dusting
granulates, liquids, in particular stabilized liquids, or slurries.
[0106] Non-dusting granulates may be produced, e.g., as disclosed in
US 4,106,991 and
4,661,452 and may optionally be coated by methods known in the art. Examples of waxy coating
materials are poly(ethylene oxide) products (polyethyleneglycol, PEG) with mean molar
weights of 1000 to 20000; ethoxylated nonylphenols having from 16 to 50 ethylene oxide
units; ethoxylated fatty alcohols in which the alcohol contains from 12 to 20 carbon
atoms and in which there are 15 to 80 ethylene oxide units; fatty alcohols; fatty
acids; and mono- and di- and triglycerides of fatty acids. Examples of film-forming
coating materials suitable for application by fluid bed techniques are given in
GB 1483591. Liquid enzyme preparations may, for instance, be stabilized by adding a polyol such
as propylene glycol, a sugar or sugar alcohol, lactic acid or boric acid according
to established methods. Protected enzymes may be prepared according to the method
disclosed in
EP 238216.
Adjunct materials
[0107] Any detergent components known in the art for use in laundry detergents may also
be utilized. Other optional detergent components include anti-corrosion agents, anti-shrink
agents, anti-soil redeposition agents, anti-wrinkling agents, bactericides, binders,
corrosion inhibitors, disintegrants/disintegration agents, dyes, enzyme stabilizers
(including boric acid, borates, CMC, and/or polyols such as propylene glycol), fabric
conditioners including clays, fillers/processing aids, fluorescent whitening agents/optical
brighteners, foam boosters, foam (suds) regulators, perfumes, soil-suspending agents,
softeners, suds suppressors, tarnish inhibitors, and wicking agents, either alone
or in combination. Any ingredient known in the art for use in laundry detergents may
be utilized. The choice of such ingredients is well within the skill of the artisan.
[0108] Dispersants - The detergent compositions of the present invention can also contain dispersants.
In particular powdered detergents may comprise dispersants. Suitable water-soluble
organic materials include the homo- or co-polymeric acids or their salts, in which
the polycarboxylic acid comprises at least two carboxyl radicals separated from each
other by not more than two carbon atoms. Suitable dispersants are for example described
in
Powdered Detergents, Surfactant science series volume 71, Marcel Dekker, Inc.
[0109] Dye Transfer Inhibiting Agents - The detergent compositions of the present invention may also include one or more
dye transfer inhibiting agents. Suitable polymeric dye transfer inhibiting agents
include, but are not limited to, polyvinylpyrrolidone polymers, polyamine N-oxide
polymers, copolymers of N-vinylpyrrolidone and N-vinylimidazole, polyvinyloxazolidones
and polyvinylimidazoles or mixtures thereof. When present in a subject composition,
the dye transfer inhibiting agents may be present at levels from about 0.0001 % to
about 10%, from about 0.01 % to about 5% or even from about 0.1 % to about 3% by weight
of the composition.
[0110] Fluorescent whitening agent - The detergent compositions of the present invention will preferably also contain
additional components that may tint articles being cleaned, such as fluorescent whitening
agent or optical brighteners. Where present the brightener is preferably at a level
of about 0.01 % to about 0.5%. Any fluorescent whitening agent suitable for use in
a laundry detergent composition may be used in the composition of the present invention.
The most commonly used fluorescent whitening agents are those belonging to the classes
of diaminostilbene-sulfonic acid derivatives, diarylpyrazoline derivatives and bisphenyl-distyryl
derivatives. Examples of the diaminostilbene-sulfonic acid derivative type of fluorescent
whitening agents include the sodium salts of: 4,4'-bis-(2-diethanolamino-4-anilino-s-triazin-6-ylamino)
stilbene-2,2'-disulfonate, 4,4'-bis-(2,4-dianilino-s-triazin-6-ylamino) stilbene-2.2'-disulfonate,
4,4'-bis-(2-anilino-4-(
N-methyl-
N-2-hydroxy-ethylamino)-s-triazin-6-ylamino) stilbene-2,2'-disulfonate, 4,4'-bis-(4-phenyl-1,2,3-triazol-2-yl)stilbene-2,2'-disulfonate
and sodium 5-(2
H-naphtho[1,2-
d][1,2,3]triazol-2-yl)-2-[(
E)-2-phenylvinyl]benzenesulfonate. Preferred fluorescent whitening agents are Tinopal
DMS and Tinopal CBS available from Ciba-Geigy AG, Basel, Switzerland. Tinopal DMS
is the disodium salt of 4,4'-bis-(2-morpholino-4-anilino-s-triazin-6-ylamino) stilbene-2,2'-disulfonate.
Tinopal CBS is the disodium salt of 2,2'-bis-(phenyl-styryl)-disulfonate. Also preferred
are fluorescent whitening agents is the commercially available Parawhite KX, supplied
by Paramount Minerals and Chemicals, Mumbai, India. Other fluorescers suitable for
use in the invention include the 1-3-diaryl pyrazolines and the 7-alkylaminocoumarins.
[0111] Suitable fluorescent brightener levels include lower levels of from about 0.01, from
0.05, from about 0.1 or even from about 0.2 wt % to upper levels of 0.5 or even 0.75
wt%.
[0112] Soil release polymers - The detergent compositions of the present invention may also include one or more
soil release polymers which aid the removal of soils from fabrics such as cotton and
polyester based fabrics, in particular the removal of hydrophobic soils from polyester
based fabrics. The soil release polymers may for example be nonionic or anionic terephthalte
based polymers, polyvinyl caprolactam and related copolymers, vinyl graft copolymers,
polyester polyamides see for example
Chapter 7 in Powdered Detergents, Surfactant science series volume 71, Marcel Dekker,
Inc. Another type of soil release polymers are amphiphilic alkoxylated grease cleaning
polymers comprising a core structure and a plurality of alkoxylate groups attached
to that core structure. The core structure may comprise a polyalkylenimine structure
or a polyalkanolamine structure as described in detail in
WO 2009/087523 (hereby incorporated by reference). Furthermore random graft co-polymers are suitable
soil release polymers. Suitable graft co-polymers are described in more detail in
WO 2007/138054,
WO 2006/108856 and
WO 2006/113314 (hereby incorporated by reference). Other soil release polymers are substituted polysaccharide
structures especially substituted cellulosic structures such as modified cellulose
deriviatives such as those described in
EP 1867808 or
WO 2003/040279 (both are hereby incorporated by reference). Suitable cellulosic polymers include
cellulose, cellulose ethers, cellulose esters, cellulose amides and mixtures thereof.
Suitable cellulosic polymers include anionically modified cellulose, nonionically
modified cellulose, cationically modified cellulose, zwitterionically modified cellulose,
and mixtures thereof. Suitable cellulosic polymers include methyl cellulose, carboxy
methyl cellulose, ethyl cellulose, hydroxyl ethyl cellulose, hydroxyl propyl methyl
cellulose, ester carboxy methyl cellulose, and mixtures thereof.
[0113] Anti-redeposition agents - The detergent compositions of the present invention may also include one or more
anti-redeposition agents such as carboxymethylcellulose (CMC), polyvinyl alcohol (PVA),
polyvinylpyrrolidone (PVP), polyoxyethylene and/or polyethyleneglycol (PEG), homopolymers
of acrylic acid, copolymers of acrylic acid and maleic acid, and ethoxylated polyethyleneimines.
The cellulose based polymers described under soil release polymers above may also
function as anti-redeposition agents.
[0114] Other suitable adjunct materials include, but are not limited to, anti-shrink agents, anti-wrinkling agents, bactericides,
binders, carriers, dyes, enzyme stabilizers, fabric softeners, fillers, foam regulators,
hydrotropes, perfumes, pigments, sod suppressors, solvents, and structurants for liquid
detergents and/or structure elasticizing agents.
Formulation of detergent products
[0115] The detergent composition of the invention may be in any convenient form, e.g., a
bar, a homogenous tablet, a tablet having two or more layers, a pouch having one or
more compartments, a regular or compact powder, a granule, a paste, a gel, or a regular,
compact or concentrated liquid.
[0116] The detergent pouch of the present invention is configured as single or multi compartments
(see
e.g.,
WO 2009/098660 or
WO 2010/141301). It can be of any form, shape and material which is suitable for holding the detergent
composition, e.g., without allowing release of the composition from the pouch prior
to water contact. The pouch is made from water-soluble film which encloses the inner
volume (detergent composition). Said inner volume can be divided into compartments
of the pouch. The water-soluble film is described above under "Water-soluble film".
The pouch can comprise a solid laundry cleaning (detergent) composition or selected
components thereof, and/or a liquid cleaning composition or selected components thereof,
separated by the water-soluble film. The pouch may include compartments having any
combination of solids and liquids, both in one or more separate compartments, and
in shared compartments containing both solid and liquid ingredients. The pouch may
include regions or compartments formed by different water-soluble films, which can
be with or without enzymes. Accordingly, detergent ingredients can be separated physically
from each other in different compartments, or in different layers of a tablet if the
detergent is in that physical form. Thereby negative storage interaction between components
can be avoided. Different dissolution profiles of each of the compartments can also
give rise to delayed dissolution of selected components in the wash solution.
[0117] A liquid or gel detergent , which is not unit dosed, may be aqueous, typically containing
at least 20% by weight and up to 95% water, such as up to about 70% water, up to about
65% water, up to about 55% water, up to about 45% water, up to about 35% water. Other
types of liquids, including without limitation, alkanols, amines, diols, ethers and
polyols may be included in an aqueous liquid or gel. An aqueous liquid or gel detergent
may contain from 0-30% organic solvent. A liquid or gel detergent may be non-aqueous.
Compositions, methods and uses
[0118] The inventors of the present invention have provided water-soluble films with improved
enzymatic storage stability and/or improved residual enzymatic activity.
[0119] Accordingly, in a first aspect, the present invention provides a water-soluble film
comprising a protease and a protease inhibitor. Preferably the protease is a serine
protease, more preferably a subtilisin.
[0120] In an embodiment, the water-soluble film comprises one or more other enzymes selected
from the group consisting of lipase, cutinase, amylase, carbohydrase, cellulase, pectinase,
mannanase, arabinase, galactanase, xylanase, laccase, peroxidase and haloperoxidase.
[0121] In an embodiment, the protease inhibitor is a boronic acid derivative, preferably
a phenyl boronic acid derivative, more preferably 4-formyl-phenyl-boronic acid (4-FPBA).
[0122] In another embodiment, the protease inhibitor is a peptide aldehyde protease inhibitor,
preferably a hydrosulfite adduct of a peptide aldehyde protease inhibitor.
[0123] In an embodiment, the water-soluble film comprises from 35% to 90% of PVOH which
has a degree of hydrolysis of from 75% to 99%.
[0124] In an embodiment, the water-soluble film comprises from 10% to 50% of polyols.
[0125] In an embodiment, the water-soluble film has a thickness of from 10 µm to 500 µm.
[0126] In a second aspect, the invention provides a method for producing the water-soluble
film described above, comprising: (a) adding a protease and a protease inhibitor to
a liquid water-soluble film composition; and (b) forming a solid water-soluble film
from the liquid composition. Preferably the protease is a serine protease, more preferably
a subtilisin.
[0127] In an embodiment, one or more other enzymes selected from the group consisting of
lipase, cutinase, amylase, carbohydrase, cellulase, pectinase, mannanase, arabinase,
galactanase, xylanase, laccase, peroxidase and haloperoxidase are also added to the
liquid composition in step (a).
[0128] In a third aspect, the invention provides a method for preparing a detergent unit
dose product, comprising: (a) forming an enzymatic water-soluble film comprising a
protease and a protease inhibitor, as described above; and (b) encapsulating a detergent
composition in the enzymatic water-soluble film. Preferably the protease is a serine
protease, more preferably a subtilisin.
[0129] In an embodiment, the detergent composition is a liquid laundry or dish wash detergent
composition.
[0130] In another aspect, the invention provides a detergent composition, comprising a surfactant
and/or a detergent builder, and a water-soluble film comprising a protease and a protease
inhibitor, as described above.
[0131] In an embodiment, the surfactant and/or a detergent builder is encapsulated in the
water-soluble film.
[0132] The invention also provides for use of the methods and compositions above for improving
enzymatic storage stability and/or improving residual enzymatic activity in the water-soluble
films described above.
[0133] The present invention is further described by the following examples that should
not be construed as limiting the scope of the invention.
EXAMPLE 1
[0134] We prepared two different enzyme containing water-soluble films, as outlined in Table
1 below. The films were produced under normal film production conditions. Later, the
films were analyzed to estimate the enzymatic activity remaining after the production
process, i.e., the percentage of residual enzymatic activity in the final film product,
as compared to the amount of enzyme added in the production process.
[0135] The protease used for preparing the films was Savinase (Novozymes A/S, Denmark),
which was added to obtain a final concentration of 1.1 % wt active enzyme protein
in both of the water-soluble films.
[0136] The amylase used was Stainzyme (Novozymes A/S, Denmark), which was added to obtain
a final concentration of 0.1 % wt active enzyme protein in both of the films.
[0137] The mannanase used was Mannaway (Novozymes A/S, Denmark), which was added to obtain
a final concentration of 0.03% wt active enzyme protein in both of the films.
[0138] The protease inhibitor used was 4-formyl-phenyl-boronic acid (4-FPBA), which was
added to obtain a final concentration of 0.5% wt in one of the water-soluble films.
[0139] Since the humidity of the samples was not controlled, some of the absolute values
from the analysis are above 100%. However, all film samples were treated identically
and analyzed at the same time, and therefore the relative improvement by using the
protease inhibitor can be calculated.
Table 1. The data are based on an average of three analyses of each film.
Enzyme |
Residual activity in film made without 4-FPBA |
Residual activity in film made with 4-FPBA |
Relative improvement by using inhibitor |
Protease |
87% |
93% |
7% |
Amylase |
106% |
114% |
8% |
Mannanase |
1% |
63% |
~600% |
[0140] The data in Table 1 show quite clearly that the presence of a protease inhibitor
during production of the film improves the survival of the enzymes in the process.
This is of even higher importance if offcuts, fragments or leftovers of film are recycled
in the process, to avoid discarding valuable material.